+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acute Repetitive Seizures Market by Drug Type (Branded, Generic), Route Of Administration (Buccal, Intramuscular, Intranasal), Distribution Channel, End User, Age Group, Formulation - Global Forecast 2025-2030- Product Image
Acute Repetitive Seizures Market by Drug Type (Branded, Generic), Route Of Administration (Buccal, Intramuscular, Intranasal), Distribution Channel, End User, Age Group, Formulation - Global Forecast 2025-2030- Product Image
Sale

Acute Repetitive Seizures Market by Drug Type (Branded, Generic), Route Of Administration (Buccal, Intramuscular, Intranasal), Distribution Channel, End User, Age Group, Formulation - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888506
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Acute Repetitive Seizures Market is undergoing dynamic change, shaped by advances in patient-centric care, innovative therapies, and strategic responses to evolving regulatory and supply-chain challenges. Decision-makers navigating this landscape require actionable insights into emerging technologies, regional trends, and key market drivers to make informed choices about growth and investment.

Market Snapshot: Acute Repetitive Seizures Market Overview

The acute repetitive seizures market grew from USD 10.46 billion in 2024 to USD 11.66 billion in 2025. It is projected to maintain a strong compound annual growth rate (CAGR) of 10.91%, positioning itself to reach USD 19.48 billion by 2030. This expansion is driven by demand for rapid intervention therapies, advances in drug delivery technology, and shifting care models that place greater emphasis on home-based and outpatient solutions.

Scope & Segmentation

This report delivers an in-depth analysis of the acute repetitive seizures market, segmented to support precise strategic planning. Stakeholders can expect detailed insights across the following categories:

  • Drug Type: Branded, Generic
  • Route of Administration: Buccal (Midazolam), Intramuscular (Midazolam), Intranasal (Diazepam, Midazolam), Intravenous (Diazepam, Lorazepam), Rectal (Diazepam)
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • End User: Home Care, Hospitals, Specialty Clinics
  • Age Group: Adult, Geriatric, Pediatric
  • Formulation: Auto Injector, Nebulizer, Solution
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (selected countries), Asia-Pacific (China, India, Japan, Australia, South Korea, and more)
  • Company Coverage: UCB S.A., Pfizer Inc., Neurelis, Inc., Aquestive Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, and Mallinckrodt Pharmaceuticals

Key Takeaways

  • Innovative intranasal and buccal formulations are reshaping acute repetitive seizure management by providing noninvasive, rapidly absorbed alternatives that enhance ease of use for patients and caregivers.
  • Adoption of digital health tools, including seizure detection wearables and telemedicine platforms, is enabling real-time intervention and supporting a shift toward decentralized, home-based care environments.
  • Healthcare providers prioritize treatment options that balance efficacy, safety, and usability across diverse patient populations, leading to a move toward patient-centric models in clinical practice.
  • Regulatory and payer dynamics, particularly value-based contracting, are influencing market strategy by rewarding manufacturers that can demonstrate improved therapeutic outcomes and device integration.
  • Segment-specific considerations, such as unique needs in pediatric or geriatric populations and the influence of user-friendly auto injectors, are increasingly informing product development and go-to-market tactics.

Tariff Impact

Recent United States tariff adjustments have created new complexities for manufacturers of acute repetitive seizure therapies. Import duties on key pharmaceutical ingredients and specialized delivery devices have led to increased production costs. Companies are responding by reassessing sourcing strategies, pursuing supply diversification, and in some cases, relocating manufacturing. These changes necessitate updated risk management and pricing approaches, with downstream impacts on reimbursement negotiations and overall market accessibility.

Methodology & Data Sources

The analysis draws on primary and secondary research, including in-depth interviews with clinical experts, consultation with regulators, and a review of peer-reviewed literature and industry filings. Quantitative insights are derived from proprietary databases on drug utilization and device trends. All findings have been validated through triangulation and independent expert review to ensure accuracy and relevance.

Why This Report Matters

  • Empowers strategic planning by providing granular segmentation and benchmarking against leading manufacturers within the acute repetitive seizures market.
  • Equips senior decision-makers to anticipate regulatory, technological, and supply chain shifts, enabling faster and more informed portfolio or partnership decisions.

Conclusion

This report delivers a comprehensive view of evolving opportunities and challenges in acute repetitive seizure care. Executives will gain clarity to drive innovation, optimize market access, and confidently address emerging patient and provider needs.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of novel rescue medications offering rapid seizure control and improved patient compliance
5.2. Expansion of telemedicine platforms enhancing remote monitoring and management of acute seizure clusters
5.3. Ongoing clinical trials for cannabinoid-based therapies targeting refractory acute seizure syndromes in adults
5.4. Strategic collaborations between biotech firms and hospitals to accelerate emergency seizure care protocols
5.5. Integration of wearable seizure detection devices with AI-driven predictive analytics for proactive intervention
5.6. Regulatory approvals of intranasal benzodiazepines transforming the acute repetitive seizure treatment landscape
5.7. Increasing focus on pediatric acute seizure management driving specialized formulation innovations
5.8. Growing investment in hospital emergency response infrastructure to address severe seizure clusters efficiently
5.9. Emergence of real-world evidence studies influencing payer reimbursement decisions for rescue therapies
5.10. Development of patient support programs and digital adherence tools to improve acute seizure medication adherence
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Acute Repetitive Seizures Market, by Drug Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Acute Repetitive Seizures Market, by Route Of Administration
9.1. Introduction
9.2. Buccal
9.2.1. Midazolam
9.3. Intramuscular
9.3.1. Midazolam
9.4. Intranasal
9.4.1. Diazepam
9.4.2. Midazolam
9.5. Intravenous
9.5.1. Diazepam
9.5.2. Lorazepam
9.6. Rectal
9.6.1. Diazepam
10. Acute Repetitive Seizures Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy
11. Acute Repetitive Seizures Market, by End User
11.1. Introduction
11.2. Home Care
11.3. Hospitals
11.4. Specialty Clinics
12. Acute Repetitive Seizures Market, by Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatric
12.4. Pediatric
13. Acute Repetitive Seizures Market, by Formulation
13.1. Introduction
13.2. Auto Injector
13.3. Nebulizer
13.4. Solution
14. Americas Acute Repetitive Seizures Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Acute Repetitive Seizures Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Acute Repetitive Seizures Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. UCB S.A.
17.3.2. Pfizer Inc.
17.3.3. Neurelis, Inc.
17.3.4. Aquestive Therapeutics, Inc.
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Viatris Inc.
17.3.7. Sandoz International GmbH
17.3.8. Sun Pharmaceutical Industries Ltd.
17.3.9. Hikma Pharmaceuticals PLC
17.3.10. Mallinckrodt Pharmaceuticals
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ACUTE REPETITIVE SEIZURES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ACUTE REPETITIVE SEIZURES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ACUTE REPETITIVE SEIZURES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ACUTE REPETITIVE SEIZURES MARKET: RESEARCHAI
FIGURE 28. ACUTE REPETITIVE SEIZURES MARKET: RESEARCHSTATISTICS
FIGURE 29. ACUTE REPETITIVE SEIZURES MARKET: RESEARCHCONTACTS
FIGURE 30. ACUTE REPETITIVE SEIZURES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ACUTE REPETITIVE SEIZURES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY MIDAZOLAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY LORAZEPAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY LORAZEPAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DIAZEPAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AUTO INJECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY NEBULIZER, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ACUTE REPETITIVE SEIZURES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 131. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 136. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 137. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 138. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 139. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 140. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 141. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 142. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 143. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 144. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 145. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 150. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 151. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 160. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 161. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 166. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 167. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 172. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 173. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 270. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 271. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 272. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 273. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 274. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 275. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 276. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 277. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 286. GERMANY ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 287. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 288. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 289. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 292. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 293. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 294. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 295. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 296. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 297. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 298. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 299. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 300. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 301. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 308. FRANCE ACUTE REPETITIVE SEIZURES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY BUCCAL, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRANASAL, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY RECTAL, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA ACUTE REPETITIVE SEIZURES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA ACUTE REPETITIVE SEIZURES MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Acute Repetitive Seizures market report include:
  • UCB S.A.
  • Pfizer Inc.
  • Neurelis, Inc.
  • Aquestive Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals PLC
  • Mallinckrodt Pharmaceuticals

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.48 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030 - Product Image

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Lacosamide Injection Market by Indication (Generalized Tonic Clonic Seizures, Partial Onset Seizures), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End Use, Therapy Type, Strength, Packaging Type - Global Forecast 2025-2030 - Product Image

Lacosamide Injection Market by Indication (Generalized Tonic Clonic Seizures, Partial Onset Seizures), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), End Use, Therapy Type, Strength, Packaging Type - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Epilepsy Drugs Market by Generation Type, Anti-Epileptics Drugs Type, Distribution Channel, and Region 2025-2033 - Product Image

Epilepsy Drugs Market by Generation Type, Anti-Epileptics Drugs Type, Distribution Channel, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Anticonvulsants Market by Drug Class (Benzodiazepines, Carbonic Anhydrase Inhibitors, Gaba Analogues), Indication (Bipolar Disorder, Epilepsy, Migraine Prophylaxis), Route Of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Image

Anticonvulsants Market by Drug Class (Benzodiazepines, Carbonic Anhydrase Inhibitors, Gaba Analogues), Indication (Bipolar Disorder, Epilepsy, Migraine Prophylaxis), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.